Uterine fibroids are benign (noncancerous) tumors of the uterus (womb) that occur in about 66% of women by the time they reach the age of 50. Fibroids are tumors of the smooth muscle cells of the uterus. The collagen content of the tumor gives it a hard, fibrous texture, thus the name fibroid. These tumors are also called leiomyomata or myomas . The cause of uterine fibroids is unknown. There is a familial predisposition, with a 2- to 3-fold increased risk if a mother or sister is affected. African American women are 3 times more likely to be affected than other women. In African American women these tumors can occur at an earlier age and are often larger and more symptomatic. In some women fibroids do not cause symptoms and do not require any treatment. In many women fibroids cause abnormal uterine bleeding and pelvic discomfort. The January 7, 2009, issue of JAMA includes an article about a woman with uterine fibroids.
Abnormal uterine bleeding with longer, heavier menstrual periods. Bleeding between menstrual periods occurs in some women.
Fatigue caused by anemia (low blood count) from excessive menstrual blood loss.
Pelvic pressure when fibroid tumor growth causes an enlarged uterus.
Urinary frequency when the enlarged uterus presses on the bladder.
Pain in the pelvic region due to worsening menstrual cramps or pressure from the fibroids on other internal organs.
Infertility preventing pregnancy in some women; in others, miscarriage can occur.
Grahic Jump Location
Pelvic examination to feel for the presence of fibroids.
Transvaginal ultrasound uses sound waves from a probe inserted in the vagina to determine the size of the uterus and the size and location of any fibroid tumors.
Hysteroscopy is a visual inspection of the interior of the uterus using a small, slender device.
Uterine fibroids that cause no symptoms do not require any treatment. Other treatment options vary depending on the size, location, and number of tumors. Treatment also depends on whether the woman wishes to maintain fertility.
In some women the tumors can be resected during a hysteroscopy procedure.
Myomectomy is the surgical removal of fibroids that preserves the uterus and allows the woman to maintain fertility.
Uterine artery embolization (UAE) is a nonsurgical procedure that blocks the blood flow to the main artery supplying the uterus. This results in shrinkage of fibroids and causes a reduction in the amount of blood loss from menstrual bleeding. There is a chance that fertility will not be maintained for some women.
A hormone-releasing intrauterine device releases progesterone, one of the female hormones, and can be placed inside the uterus to reduce the amount of uterine bleeding in some women with small fibroids
Hysterectomy is surgical removal of the uterus, ending menstrual periods and causing infertility.
American College of Obstetricians and Gynecologists http://www.acog.org/publications/patient_education
To find this and other JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on hysterectomy was published in the March 24/31, 2004, issue.
Source: American College of Obstetricians and Gynecologists
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: WOMEN'S HEALTH
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.